Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma.

Rochigneux P, Nault JC, Mallet F, Chretien AS, Barget N, Garcia AJ, Del Pozo L, Bourcier V, Blaise L, Grando-Lemaire V, N'Kontchou G, Nahon P, Seror O, Ziol M, Ganne-Carrié N, Olive D.

Oncoimmunology. 2019 May 25;8(8):1615818. doi: 10.1080/2162402X.2019.1615818. eCollection 2019.

2.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Hézode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.

3.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

Hézode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourlière M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Métivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.

PMID:
23669289
4.

Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients.

Nkontchou G, Tran Van Nhieu J, Ziol M, Tengher I, Mahmoudi A, Roulot D, Bourcier V, Ganne Carrie N, Grando-Lemaire V, Trinchet JC, Cherqui D, Beaugrand M.

Eur J Gastroenterol Hepatol. 2013 Jan;25(1):94-8. doi: 10.1097/MEG.0b013e328357cdd7.

PMID:
23085575
5.

Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis.

Nkontchou G, Aout M, Mahmoudi A, Roulot D, Bourcier V, Grando-Lemaire V, Ganne-Carrie N, Trinchet JC, Vicaut E, Beaugrand M.

Cancer Prev Res (Phila). 2012 Aug;5(8):1007-14. doi: 10.1158/1940-6207.CAPR-11-0450. Epub 2012 Apr 23.

6.

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.

Nkontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, Roulot D, Ganne-Carrie N, Grando-Lemaire V, Trinchet JC, Gordien E, Vicaut E, Baghad I, Beaugrand M.

J Viral Hepat. 2011 Oct;18(10):e516-22. doi: 10.1111/j.1365-2893.2011.01441.x.

PMID:
21914071
7.

A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.

Nahon P, Sutton A, Rufat P, Charnaux N, Mansouri A, Moreau R, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Pessayre D, Beaugrand M.

J Hepatol. 2012 Feb;56(2):426-32. doi: 10.1016/j.jhep.2011.08.010. Epub 2011 Sep 8.

PMID:
21907168
8.

Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.

Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, Ganne-Carrie N, Grando-Lemaire V, Vicaut E, Trinchet JC, Beaugrand M.

J Clin Endocrinol Metab. 2011 Aug;96(8):2601-8. doi: 10.1210/jc.2010-2415. Epub 2011 Jul 13.

PMID:
21752887
9.

Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.

Nkontchou G, Bastard JP, Ziol M, Aout M, Cosson E, Ganne-Carrie N, Grando-Lemaire V, Roulot D, Capeau J, Trinchet JC, Vicaut E, Beaugrand M.

J Hepatol. 2010 Nov;53(5):827-33. doi: 10.1016/j.jhep.2010.04.035. Epub 2010 Jul 14.

PMID:
20728234
10.

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, Charnaux N, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Gattegno L, Pessayre D, Beaugrand M.

Hepatology. 2009 Nov;50(5):1484-93. doi: 10.1002/hep.23187.

PMID:
19731237
11.

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.

Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, Grando-Lemaire V, Trinchet JC, Beaugrand M.

Aliment Pharmacol Ther. 2008 Nov 1;28(9):1102-10. doi: 10.1111/j.1365-2036.2008.03825.x.

12.

Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin.

Braks RE, Ganne-Carrie N, Fontaine H, Paries J, Grando-Lemaire V, Beaugrand M, Pol S, Trinchet JC.

World J Gastroenterol. 2007 Nov 14;13(42):5648-53.

13.

Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C.

Nahon P, Thabut G, Ziol M, Htar MT, Cesaro F, Barget N, Grando-Lemaire V, Ganne-Carrie N, Trinchet JC, Beaugrand M.

Am J Gastroenterol. 2006 Dec;101(12):2744-51.

PMID:
17227522
14.

Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.

N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, Trinchet JC, Beaugrand M.

Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. Epub 2006 Jul 14.

PMID:
16844421
15.

[Predictive factors for progression to cirrhosis in chronic liver diseases].

Grando-Lemaire V, Kazemi F, Trinchet JC.

Rev Prat. 2005 Sep 30;55(14):1533-5, 1537-8. French.

PMID:
16255294
16.

Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.

N'Kontchou G, Seror O, Bourcier V, Mohand D, Ajavon Y, Castera L, Grando-Lemaire V, Ganne-Carrie N, Sellier N, Trinchet JC, Beaugrand M.

Eur J Gastroenterol Hepatol. 2005 Feb;17(2):179-84.

PMID:
15674095
17.

[Diagnosis of cirrhosis].

Trinchet JC, Grando-Lemaire V.

Gastroenterol Clin Biol. 2004 May;28(5 Suppl):D121-8. Review. French. No abstract available.

18.

[Percutaneous ablation of hepatocellular carcinoma].

Sitruk V, Seror O, Grando-Lemaire V, Mohand D, N'Kontchou G, Ganne-Carrie N, Beaugrand M, Sellier N, Trinchet JC.

Gastroenterol Clin Biol. 2003 Apr;27(4):381-90. Review. French. No abstract available.

19.

[Hepatitis C virus screening in drug users in an addiction out-patient unit].

Grando-Lemaire V, Goisset P, Sorge F, Trinchet JC, Castera L, Roulot D, Sitruk V, Beaugrand M.

Gastroenterol Clin Biol. 2002 Dec;26(12):1091-6. French.

20.

[Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis].

Ganne-Carrié N, Mohand D, N'kontchou G, Grando-Lemaire V, Trinchet JC.

Gastroenterol Clin Biol. 2002 Jan;26(1):73-7. Review. French. No abstract available.

21.

[Acute cholestatic hepatitis induced by glimepiride].

Sitruk V, Mohib S, Grando-Lemaire V, Ziol M, Trinchet JC.

Gastroenterol Clin Biol. 2000 Dec;24(12):1233-4. French. No abstract available.

22.

Supplemental Content

Loading ...
Support Center